Ontario invests in $580 million gene and cell therapy facility in Hamilton

The Ontario government is making a significant investment to help fund a state-of-the-art cell and gene therapy facility in Hamilton to take the life sciences sector to the next level.

The $580-million-facility being built at Hamilton’s McMaster Innovation Park will anchor the future of life sciences jobs and innovation in Ontario while advancing pioneering medicine with the potential to cure many forms of cancer, cardiovascular disease, Parkinson’s disease and diabetes.

During an announcement on Thursday, trade minister Vic Fedeli said the Ford government is shoring up to an additional $40 million to help OmniaBio, a Canadian cell and gene therapy contract development and manufacturing organization, construct two buildings in the complex.

The project is expected to create at least 250 new jobs by 2031.